Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis

Journal of Pathology

Volumn 179, Issue 2, 1996, Pages 169-176

  Poddighe, Pino J ^a,b   Bringuier, Pierre Paul ^b   Vallinga, Monique ^a   Schalken, Jack A ^b   Ramaekers, Frans C S ^a   Hopman, Anton H N ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

bladder cancer; chromosome aberrations; in situ hybridization; RFLP analysis

Indexed keywords

ARTICLE; BLADDER CANCER; CENTROMERE; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CYTOGENETICS; DNA PROBE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERPHASE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA;

BLOTTING, SOUTHERN; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; HUMANS; IN SITU HYBRIDIZATION; INTERPHASE; PLOIDIES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; URINARY BLADDER NEOPLASMS;

EID: 0029941311     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199606)179:2<169::AID-PATH568>3.0.CO;2-J     Document Type: Article

References (55)

1. Cummings KB. Carcinoma of the bladder: predictors. Cancer 1980; 45: 1849-1855.
2. Tribukait B, Gustafson H, Esposti PL. The significancy of policy and biological evaluation of bladder tumours: a study of 100 untreated cases. Br J Urol 1982; 54: 130-135.
3. Pauwels RPE, Schapers RFM, Smeets AWGB, Geraedts JPM, Debruyne FMJ. Grading in superficial bladder cancer. I. Morphological criteria. Br J Urol 1987; 61: 129-134.
4. Tribukait B, Granberg-Ohman I, Wijkstrom H. Flow cytometric DNA and cytogenetic studies in human tumors: a comparison and discussion of the differences in modal values obtained by two methods. Cytometry 1986; 7: 194-199.
5. Blomjous CEM, Schipper NW, Baak JPA, van Galen EM, de Voogt HJ, Meyer CJLM. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma. J Clin Pathol 1988; 41: 21-25.
6. Koss LG, Czernick B, Herz F, Werstro RP. Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. Hum Pathol 1989; 20: 528-548.
7. Teyssier JR. The chromosomal analysis of human solid tumors. Cancer Genet Cytogenet 1989; 37: 103-125.
8. Smeets WGB, Pauwels RPE, Laarakkers L, Debruyne FMJ, Geraedts JPM. Chromosomal analysis of bladder cancer. III. Nonrandom alterations. Cancer Genet Cytogenet 1987; 29: 29-41.
9. Kovacs G. Serial cytogenetic analysis in a patient with pseudodiploid bladder cancer. J Cancer Res Clin Oncol 1985; 110: 249-251
10. Sandberg AA. Chromosome changes in bladder cancer: clinical and other correlations. Cancer Genet Cytogenet 1986; 19: 163-175.
11. Vanni R, Scarpa RM, Nieddu N, Usai E. Cytogenetic investigation on 30 bladder carcinomas. Cancer Genet Cytogenet 1988; 30: 35-42.
12. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
13. Tsai YC, Nichols PW, Hiti AL, Williams Z, Skinner DG, Jones PA. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res 1990; 50: 44-47.
14. Olumni F, Tsai YC, Nichols PW, et al. Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res 1990; 50: 7081-7083.
15. Sidransky D, Frost P, von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin of bladder cancer. N Engl J Med 1992; 326: 737-740.
16. Sidransky D, von Eschenbach A, Tsai YC, et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 1991; 252: 706-709.
17. Presti JC, Reuter VE, Galan T, Fair WR, Cordon-Cardo C. Molecular genetic alterations in superficial and locally advanced bladder cancer. Cancer Res 1991; 51: 5405-5409.
18. Proctor AJ, Coombes LM, Cairns JP, Knowles MA. Amplification at chromosome 11q13 in transitional cell tumours of the bladder. Oncogene 1991; 6: 789-795.
19. Ruppert JM, Tokino K, Sidransky D. Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 1993; 53: 579-584.
20. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon-Cardo C. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 1994; 54: 2848-2851.
21. Cremer T, Tessin D, Hopman AHN, Manuelidis L. Rapid interphase and metaphase assessment of specific chromosomal changes in neuroectodermal tumor cells by in situ hybridization with chemically modified DNA probes. Exp Cell Rex 1988; 176: 199-206.
22. Raap AK, Arnoldus EPJ, Nederlof PM, Smit VTHBM, Cornelisse CJ, Van der Ploeg M. Detection of numerical and structural chromosome aberrations in interphase nuclei by fluorescence in situ hybridisation. In: Elder HY, ed. Transactions of the Royal Microscopic Society. London: Royal Microscopic Society, 1900; 661-667.
23. Poddighe PJ, Ramaekers FCS, Hopman AHN. Interphase cytogenetics of tumours. J Pathol 1992; 166: 215-224.
24. Hopman AHN, Poddighe PJ, Moesker O, Ramaekers FCS. Interphase cytogenetics. An approach in the detection of genetic aberrations in cancers. In: McGee JO'D. Herrington CS, eds. Diagnostic Molecular Pathology: A Practical Approach. Oxford: IRL. Oxford University Press, 1992: 141-167.
25. Hopman AHN. van Hooren E, van de Kaa CA, Vooijs GP, Ramaekers FCS. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod Pathol 1990; 4: 503-513.
26. Arnoldus EPJ, Dreef EJ, Noordermeer IA, et al. Feasibility of in situ hybridization with chromosome specific DNA probes on paraffin wax embedded tissue. J Clin Pathol 1991; 44: 900-904.
27. Naoumov NV, Alexander GJM, Eddleston ALWF, Williams R. In situ hybridisation in formalin fixed, paraffin wax embedded liver specimens: method for detecting human and viral DNA using biotinylated probes. J Clin Pathol 1988; 41: 793-798.
28. Kim SY, Lee JS, Ro JY, Gay ML, Hong WK, Hittelman WN. Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Am J Pathol 1993; 142: 307-317.
29. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast TH, van Dekken H. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chrom Cancer 1995; 12: 241-250.
30. Looijenga LH, Gillis AJ, Van Putten WL, Oosterhuis JW. In situ numeric analysis of centromeric regions of chromosomes I. 12, and 15 of seminomas, nonseminomatous germ cell tumors, and carcinoma In situ of human testis. Lab Invest 1993; 68: 211-219.
31. Hopman AHN, Moesker O, Smeets WGB, Pauwels RPE, Vooijs GP, Ramaekers FCS. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 1991; 51: 644-651.
32. Hopman AHN, Poddighe PJ, Smeets WGB, et al. Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am J Pathol 1989; 135: 1105-1117.
33. Cooke HJ, Hindley J. Cloning of human satellite III DNA: different components are on different chromosomes. Nucleic Acid Res 1979; 6: 3177-3197.
34. Waye JS, England SB, Willard HF. Genomic organization of alpha satellite DNA on human chromosome 7: evidence for two distinct alphoid domains on a single chromosome. Mol Cell Biol 1987; 7: 349-456.
35. Moyzis RK, Albright KL, Bartholdi MF, et al. Human chromosome-specific repetitive DNA sequences: novel markers for genetic analysis. Chromosoma 1987; 95: 375-382.
36. Devilee P, Kievits T, Waye JS, Pearson PL, Willard HF. Chromosome-specific alpha satellite DNA: isolation and mapping of a polymorphic alphoid repeat from human chromosome 10. Genomics 1988; 3: 1-7.
37. Waye JS, Creeper LA, Willard HF. Organization and evolution of alpha satellite DNA from human chromosome II. Chromosoma 1987; 95: 182-188.
38. Waye JS, Willard HF. Molecular analysis of a deletion polymorphism in alpha satellite of human chromosome 17: evidence for homologous unequal crossing-over and subsequent fixation. Nucleic Acid Res 1986; 14: 6915-6927.
39. Devilee P, Cremer T, Slagboom P, et al. Two subsets of human alphoid repetitive DNA show distinct preferential localization of the pericentromeric regions of chromosomes 13, 18 and 21. Cytogenet Cell Genet 1986; 41: 193-202.
40. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984; 81: 1991-1995.
41. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1988; 16: 1215.
42. Nakamura Y, Fujimoto E, O'Connell P, et al. Isolation and mapping of a polymorphic DNA sequence pEFD126.3 on chromosome 9q (D9S7). Nucleic Acid Res 1987; 15: 10607.
43. Pulciano S, Santos E, Lauver AV, Lang LK, Robbins KC, Barbacid M. Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells. Proc Natl Acad Sci USA 1982; 79: 2845-2849.
44. Mansouri A, Spurr N, Goodfellow PN, Kemler R. Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation 1988; 38: 67-71.
45. Bufton I, Mohandas TK, Magenis RE, Sheehy R, Bestwick RK, Litt M. A highly polymorphic locus on chromosome 16q revealed by a probe from a chromosome-specific cosmid library. Hum Genet 1986; 74: 425-431.
46. Schwartz CE, Lohnson JP, Holycross B, et al. Detection of submicroscopic deletions in band 17p13 in patients with the Miller-Dieker syndrome. Am J Hum Genet 1988; 43: 597-604.
47. Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990; 247: 49-56.
48. Pahlplatz MMM, de Wilde PCM, Poddighe PJ, Van Dekken H, Vooijs GP, Hanselaar AGJM. A model for evaluation of in situ hybridization spot count distributions in tissue sections. Cytometry (accepted).
49. Thompson CT, LeBoit PE, Nederlof PM, Gray JW. Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. Am J Pathol 1994; 144: 237-243.
50. Shackney SE, Snith CA, Miller BW, et al. A model for the genetic evolution of human solid tumors. Cancer Res 1989; 49: 3344-3354.
51. Cairns P, Shaw ME, Knowles MA. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res 1993; 53: 1230-1232.
52. Yamamoto FI, Clausen H, White T, Marker J, Hakomori S. Molecular genetic basis of the histo-blood group ABO-system. Nature 1990; 345: 229-233.
53. Matsumura K, Kallioniemi A, Kallioniemi O. et al. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization. Cancer Res 1992; 52: 3474-3477.
54. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 1995; 55: 467-471.
55. Sundaresan V, Ganly P, Hasleton P, Bleehen NM, Rabbitts P. Paraffin wax-embedded material as a source of DNA for the detection of somatic genetic changes. J Pathol 1993; 169: 43-52.